A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczkó(University of Pennsylvania), Michael J. Hogan(Children's Hospital of Philadelphia), Sushila A. Toulmin(Children's Hospital of Philadelphia), Philip Hicks(University of Pennsylvania), Katlyn Lederer(University of Pennsylvania), Brian T. Gaudette(University of Pennsylvania), Diana Castaño(Universidad de Antioquia), Fatima Amanat(Icahn School of Medicine at Mount Sinai), Hiromi Muramatsu(University of Pennsylvania), Thomas H. Oguin(Duke University), Amrita Ojha(Scripps Research Institute), Lizhou Zhang(Scripps Research Institute), Zekun Mu(Duke University), Robert Parks(Duke University), Tomaz B. Manzoni(University of Pennsylvania), Brianne Roper(University of Pennsylvania), Shirin Strohmeier(Icahn School of Medicine at Mount Sinai), István Tombácz(University of Pennsylvania), Leslee Arwood(Duke University), Raffael Nachbagauer(Icahn School of Medicine at Mount Sinai), Katalin Karikó(BioNTech (Germany)), Jack Greenhouse(Bioqual), Laurent Pessaint(Bioqual), Maciel Porto(Bioqual), Tammy Taylor(Bioqual), Amanda Strasbaugh(Bioqual), Tracey-Ann Campbell(Bioqual), Paulo J.C. Lin(Acuitas Therapeutics (Canada)), Ying K. Tam(Acuitas Therapeutics (Canada)), Gregory D. Sempowski(Duke University), Michael Farzan(Scripps Research Institute), Hyeryun Choe(Scripps Research Institute), Kevin O. Saunders(Duke University), Barton F. Haynes(Duke University), Hanné Andersen(Bioqual), Laurence C. Eisenlohr(Children's Hospital of Philadelphia), Drew Weissman(University of Pennsylvania), Florian Krammer(Icahn School of Medicine at Mount Sinai), Paul Bates(University of Pennsylvania), David Allman(University of Pennsylvania), Michela Locci(University of Pennsylvania), Norbert Pardi(Penn Center for AIDS Research)
Cited by 387Open Access